U.S. COMPANY FILING
GILEAD SCIENCES, INC. — Form 10-Q filed 2026-08-06
Filing text preview
Gilead reported a net loss of $10.5B in Q2 2026, driven by $12.15B in acquired IPR&D charges from acquisitions (Ouro, Tubulis, Arcellx) and a $1.75B impairment. Cash decreased by $4.385B. The company completed multiple acquisitions and paid dividends.
This preview uses text already stored in ReportGem and does not fetch the document from object storage during SEO generation. Review the internal filing record and the official SEC source before relying on it.
Open filing record